Early-stage clinical trials have produced unprecedented weight-loss results, eclipsing even the massive success of semaglutide (Ozempic) and tirzepatide (Mounjaro)
Recordings were made using a Dantec Keypoint Focus EMG system
This is remarkable progress given the historical trends with previous anti-obesity medications used (i.e., Phentermine, Low Dose Naltrexone, Orlistat, etc.) were only noted to produce an average of 3-7% total percentage of body weight lost
Oral semaglutide ($289/mo) achieves slightly lower peak blood levels than injection ($189/mo), which may result in gentler thermoregulatory effects for some users
95% CI = 1.183.61)
(This also helps with keeping your blood levels of the med as consistent as possible, which can also help keep frustrating side effects at bay.) If you accidentally miss a dose, follow the instructions provided by your healthcare provider or the medication guide